Search Ontology:

ChEBI

PS(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))

Term ID

CHEBI:88531

Synonyms

(2S)-2-amino-3-({hydroxy[(2R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxy]phosphoryl}oxy)propanoic acid
1-Arachidonoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoserine
1-Arachidonoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoserine
Phosphatidylserine(20:4/20:3)
Phosphatidylserine(20:4n6/20:3n6)
Phosphatidylserine(20:4w6/20:3w6)
Phosphatidylserine(40:7)
PS(20:4/20:3)
PS(20:4n6/20:3n6)
PS(20:4w6/20:3w6)
PS(40:7)
PSer(20:4/20:3)
PSer(20:4n6/20:3n6)
PSer(20:4w6/20:3w6)
PSer(40:7)

Definition

References

HMDB:HMDB0012437
PMID:20671299

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidyl-L-serine

phosphatidyl-L-serine Show first 5 Terms

Phenotype

Phenotype resulting from PS(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))

Phenotype where environments contain PS(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))

Phenotype modified by environments containing PS(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))

Human Disease Model